Healthcare Industry News: Edwards Lifesciences
News Release - November 4, 2013
EndoEvolution Announces the Appointment of Two Board Members
David R. Murray and Robert S. HoctorRAYNHAM, Mass.--(Healthcare Sales & Marketing Network)--EndoEvolution, LLC, a medical device company and the leader in advanced automated suturing technology, announced today that it has appointed two new members to serve on its Board of Managers.
“We are extremely pleased to be adding Dave Murray and Rob Hoctor to our Board,” said Ron Rudowsky, Chief Executive Officer of EndoEvolution. “They bring extensive medical device industry experience both in large companies and in the start-up world. Adding their knowledge and expertise to our team will be instrumental in our efforts to grow our business.”
Dave Murray has been the President of ConMed Electrosurgery since 2004, and has more than 25 years of experience in the medical device industry, including stints as President and Chief Executive Officer of Z-KAT Inc. and American Medical Systems Gynecology Inc. During his seventeen years at Johnson & Johnson, he served as Vice President of Sales & Marketing at Ethicon Inc. and President of Critikon Inc. He also served as start-up Chief Executive Officer of three other early stage medical device businesses. His prior Board experience includes Directorships at Power Medical Interventions Inc., CryoGen Inc., and CryoCor Inc. Mr. Murray holds an M.B.A. in Finance from the Wharton School of the University of Pennsylvania and a B.S. in Industrial Management from Purdue University.
Robert Hoctor has extensive, diversified global leadership experience with more than 25 years in medical devices and industry including entrepreneurial startup companies as well as major conglomerates such as, Kimberly-Clark Healthcare and Covidien. Rob has served as President of Catheter Robotics, Inc.; an early stage development company, VP and General Manager of Johnson Medtech; a division of Johnson Electric, VP Global Strategic Marketing at Covidien Surgical Solutions, VP International for Tyco Healthcare, and General Manager at US Surgical. In addition, he has held marketing roles at Kimberly-Clark Healthcare and American Hydro-Surgical Instruments. Currently, Rob is Chief Strategist at Impact Planning Group, LLC. Mr. Hoctor holds an M.B.A. from the New York Institute of Technology and a B.S. in Industrial Management from Purdue University.
About EndoEvolution
EndoEvolution, LLC, the leader in advanced automated suturing device technology, is a privately held medical device company introducing and developing the most advanced MIS (Minimally Invasive Surgery) automated suturing devices delivering significant clinical advantages and substantial cost-savings to hospitals. EndoEvolution’s devices, including the reusable Endo360° MIS suturing device and the revolutionary 5mm EndoTransformer (in development) are the only automated suturing devices using curved needles that precisely replicate the traditional method used by surgeons to place stitches and tie intracorporeal knots. Available with a full complement of standard sutures, EndoEvolution’s reusable automated suturing products are easier to use with demonstrated clinical effectiveness in a broad range of surgical procedures including bariatric, colorectal, and general surgery, as well as gynecology and urogynecology. In May of 2012, Edwards Lifesciences, the world’s leading cardiac surgery company, licensed EndoEvolution’s advanced automated suturing device technology for use in cardiac surgery.
Source: EndoEvolution
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
